Indivior says generic's appeal gets granted-in-part motion on preliminary injunction


Indivior Plc on Monday said a U.S. Court granted-in-part a motion to expedite a rival's appeal of a preliminary injunction that blocked the sale of copycat versions of the British drugmaker's bestselling opioid addiction treatment in the United States. Earlier this month, a court had granted a preliminary injunction, preventing generic rival Dr. Reddy's Laboratories from re-launching its copycat version until the patent litigation is concluded or until the company prevails on an appeal of the injunction.



from Biotech News